TGM2 and irritable bowel syndrome: Therefore, taking into account the significant potential consequences of missing the diagnosis of CD, we recommend serologic testing for CD with quantitative IgA levels and IgA anti-tissue transglutaminase (tTG) in all children with IBS symptoms if CD prevalence in the population is > 1% (as it is in Italy).